Virtus ETF Advisers LLC Fate Therapeutics Inc Transaction History

Virtus ETF Advisers LLC

  • $234 Million
  • Q4 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023
SELL
$2.02 - $5.04 $3,654 - $9,117
-1,809 Reduced 9.03%
18,216 $38,000
Q2 2023

Aug 14, 2023
BUY
$4.76 - $6.59 $63,974 - $88,569
13,440 Added 204.1%
20,025 $95,000
Q1 2023

May 15, 2023
SELL
$4.24 - $11.12 $10,718 - $28,111
-2,528 Reduced 27.74%
6,585 $37,000
Q4 2022

Feb 14, 2023
BUY
$9.86 - $23.83 $34,569 - $83,547
3,506 Added 62.53%
9,113 $91,000
Q3 2022

Nov 14, 2022
BUY
$21.04 - $36.06 $862 - $1,478
41 Added 0.74%
5,607 $126,000
Q2 2022

Aug 12, 2022
BUY
$17.78 - $42.39 $44,005 - $104,915
2,475 Added 80.07%
5,566 $138,000
Q1 2022

May 16, 2022
SELL
$29.67 - $60.28 $5,429 - $11,031
-183 Reduced 5.59%
3,091 $120,000
Q4 2021

Feb 14, 2022
BUY
$47.84 - $64.34 $43,917 - $59,064
918 Added 38.96%
3,274 $192,000
Q3 2021

Nov 15, 2021
SELL
$59.27 - $95.73 $7,705 - $12,444
-130 Reduced 5.23%
2,356 $140,000
Q2 2021

Aug 10, 2021
SELL
$67.25 - $92.52 $41,964 - $57,732
-624 Reduced 20.06%
2,486 $216,000
Q1 2021

May 17, 2021
BUY
$72.16 - $117.4 $3,535 - $5,752
49 Added 1.6%
3,110 $256,000
Q4 2020

Feb 12, 2021
SELL
$38.09 - $100.95 $265,373 - $703,318
-6,967 Reduced 69.48%
3,061 $278,000
Q3 2020

Nov 13, 2020
SELL
$30.41 - $40.5 $41,388 - $55,120
-1,361 Reduced 11.95%
10,028 $401,000
Q2 2020

Aug 05, 2020
SELL
$20.21 - $35.23 $156,546 - $272,891
-7,746 Reduced 40.48%
11,389 $391,000
Q1 2020

May 14, 2020
SELL
$17.28 - $31.88 $48,072 - $88,690
-2,782 Reduced 12.69%
19,135 $425,000
Q4 2019

Feb 13, 2020
BUY
$13.39 - $20.73 $103,651 - $160,470
7,741 Added 54.61%
21,917 $429,000
Q3 2019

Nov 12, 2019
SELL
$15.47 - $22.5 $12,205 - $17,752
-789 Reduced 5.27%
14,176 $220,000
Q2 2019

Aug 13, 2019
SELL
$15.61 - $20.44 $25,709 - $33,664
-1,647 Reduced 9.91%
14,965 $304,000
Q1 2019

May 14, 2019
SELL
$13.15 - $18.71 $22,723 - $32,330
-1,728 Reduced 9.42%
16,612 $292,000
Q4 2018

Feb 05, 2019
SELL
$11.48 - $16.98 $226,775 - $335,422
-19,754 Reduced 51.86%
18,340 $235,000
Q3 2018

Nov 14, 2018
SELL
$8.75 - $16.29 $244,816 - $455,777
-27,979 Reduced 42.35%
38,094 $621,000
Q2 2018

Aug 10, 2018
BUY
$9.16 - $13.48 $605,228 - $890,664
66,073 New
66,073 $749,000

Others Institutions Holding FATE

# of Institutions
167
Shares Held
108M
Call Options Held
79.2K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $138M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email